Skip to content
  • About the Project
    • About
    • Partners
    • Management Group
    • Advisory Group
    • Contact us
  • Research sites
    • Afghanistan
    • Colombia
    • Myanmar
  • Resources
    • Blog
    • Publications
    • Multimedia
  • News and events
    • Events
    • Press

Measuring progress towards SDG16 in Afghanistan: Ignoring the elephant in the room

Posted byAdam Pain13th April 202116th December 2021Posted inJournal Articles, Publications, Afghanistan

Viewpoint published in the International Journal of Drug Policy. By Orzala Nemat and Adam Pain

Read More

Explaining Afghanistan’s failed counter-narcotics policy and opportunities for policy engagement

Posted byAdam Pain22nd February 202122nd February 2021Posted inBlog, Afghanistan

Five reasons why counter-narcotics policy ambitions have failed in Afghanistan and reflections on what this means for those seeking to inform counter-narcotics policymaking and interventions.

Read More

Drugs and development in Afghanistan: national policy and actor analysis

Posted byAdam Pain15th February 202113th April 2021Posted inWorking Papers, Afghanistan

An overview of counter-narcotic laws, policies and programmes in Afghanistan since 2001 and what it means for policy engagement today.

Read More

Mastering the art of living with radical uncertainty in Afghanistan

Posted byAdam Pain16th April 202014th May 2020Posted inBlog, Afghanistan

While the West struggles with the uncertainty of coronavirus, for Afghanistan it’s a way of life, and opium poppy cultivation is an important part.

Read More

Main

  • About
  • Partners
  • Management Group
  • Advisory Group
  • Centre for the Study of Illicit Economies, Violence and Development
  • Contact us
  • Privacy Policy

Countries

  • Afghanistan
  • Colombia
  • Myanmar

Newsletter

Drugs and (Dis)order is funded via UK Research and Innovation as part of the Global Challenges Research Fund

© GCRF - Drugs and (Dis)order 2022. All rights reserved.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy